Vanberra Signal

Biocommunication

Curated by Signal

Developer of therapeutic solutions to treat chronic pain, allergies in animals

Overview

Developer of therapeutic solutions to treat chronic pain, allergies in animals. The company has developed the Bicom device that can read the body’s electromagnetic signals and can send out radio waves to correct the asymmetrical frequencies. It also neutralizes the distressed level that helps in treating allergies, chronic pain, musculoskeletal disorders, gastrointestinal disorders, and Lyme disease in animals. The device can be used for pain managemnt, inflammations, digestive disorders, hormonal imbalances, wound healing, and others.

Key facts

Founded
2018

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Developing technology to make organ transplant communication more efficient and effective

    Health TechnologyIowa City, United States
  • Software for clinical trial study automation and management

    Health TechnologyChicago, United States
  • AI-driven rare disease-focused differential diagnosis tool

    Health TechnologyCarlsbad, United States

About Biocommunication

What does Biocommunication do?

Developer of therapeutic solutions to treat chronic pain, allergies in animals.

Where is Biocommunication headquartered?

Biocommunication is headquartered in Rockville, United States.

When was Biocommunication founded?

Biocommunication was founded in 2018.

Which sector is Biocommunication in?

Biocommunication operates in Health Technology.

Who are Biocommunication's competitors?

Companies similar to Biocommunication include HealthTech Solutions, Anova, and RareMD.